2-tert-butylhydroquinone has been researched along with B Virus Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, NM; Benedict, CA; Bui, JD; Picarda, G; Saddawi-Konefka, R; Seelige, R; Sun, JC | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and B Virus Infection
Article | Year |
---|---|
Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection.
Topics: Animals; Cell Line, Tumor; Enzyme Inhibitors; Herpesviridae Infections; Hydroquinones; Immunity, Innate; Interleukin-17; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Muromegalovirus; Neutrophils; NF-E2-Related Factor 2; RNA Interference; RNA, Small Interfering | 2018 |